aTTP Archives -

Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option

NICE okays Roche liver cancer immunotherapy, Sanofi’s rare disease drug

https://pharmaphorum.com/news/nice-okays-roche-liver-cancer-immunotherapy-sanofis-rare-disease-drug/

The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired

Sanofi’s rare disease drug Cablivi approved in the EU

https://pharmaphorum.com/news/sanofi-cablivi-approved-europe/

New trial data will be included in US and EU filings

After more encouraging data, Ablynx to file first drug with FDA

https://pharmaphorum.com/news/ablynx-prepares-us-filing-caplacizumab-attp/

aTTP